Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions [Yahoo! Finance]
Merck's Priority Review Cancer Drug Adds To Undervalued Growth Story [Yahoo! Finance]
Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies [Yahoo! Finance]
Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies
Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase [Yahoo! Finance]